Verrica Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application for VP-102 for the Treatment of Molluscum ContagiosumGlobeNewsWire • 11/27/19
Verrica Pharmaceuticals Announces Presentation of Positive Data from Clinical Trials of VP-102 at the 2019 39th Annual Fall Clinical Dermatology ConferenceGlobeNewsWire • 10/18/19
Verrica Pharmaceuticals Appoints Eugene Scavola to the Position of Executive Vice President, Technical OperationsGlobeNewsWire • 10/09/19
Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 21st Annual Global Investment ConferenceGlobeNewsWire • 08/28/19
Verrica's Mid-Stage Results For Common Warts Put It In A Sweet Spot With FDA MeetingSeeking Alpha • 07/04/19